Managed Healthcare Executive16h
TGen Study Leverages Advanced Genomics to Map Lung Tissue Changes
Significant alterations in the structure and cellular composition of the distal lung are a defining characteristic of ...
Trevi Therapeutics, Inc.: Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates
Announced positive topline data from the Phase 2a RIVER trial in patients with refractory chronic cough (RCC), making Haduvio the first therapy in clinical development ...